TC BioPharm Correlations

TCBP Stock

USD 0.56 0.04 6.67%

The current 90-days correlation between TC BioPharm Holdings and Virios Therapeutics Llc is 0.02 (i.e., Significant diversification). The correlation of TC BioPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

TC BioPharm Correlation With Market

Significant diversification

The correlation between TC BioPharm Holdings and DJI is 0.04 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm Holdings and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Moving together with TCBP Stock

0.67	ELAN	Elanco Animal Health	Pair Corr
0.89	HLN	Haleon plc	Pair Corr
0.78	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.82	LLY	Eli Lilly	Pair Corr
0.93	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.77	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.84	RDY	Dr Reddys Laboratories	Pair Corr
0.9	TAK	Takeda Pharmaceutical	Pair Corr
0.84	ZTS	Zoetis Inc	Pair Corr
0.68	LTRN	Lantern Pharma	Pair Corr
0.73	AMGN	Amgen Inc	Pair Corr
0.65	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.88	ANRO	Alto Neuroscience,	Pair Corr

Moving against TCBP Stock

0.82	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.82	GILD	Gilead Sciences	Pair Corr
0.78	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.74	EWTX	Edgewise Therapeutics	Pair Corr
0.67	VTRS	Viatris	Pair Corr
0.67	EBS	Emergent Biosolutions	Pair Corr
0.59	BHC	Bausch Health Companies	Pair Corr
0.55	WAT	Waters	Pair Corr
0.46	GANX	Gain Therapeutics	Pair Corr
0.34	BCTXW	BriaCell Therapeutics	Pair Corr
0.77	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.72	BSX	Boston Scientific Corp Sell-off Trend	Pair Corr
0.71	MNMD	Mind Medicine	Pair Corr
0.69	DXCM	DexCom Inc Sell-off Trend	Pair Corr
0.53	MOLN	Molecular Partners	Pair Corr
0.53	ABT	Abbott Laboratories Sell-off Trend	Pair Corr
0.45	CMND	Clearmind Medicine Common	Pair Corr
0.39	NBIX	Neurocrine Biosciences	Pair Corr
0.36	EW	Edwards Lifesciences Corp	Pair Corr

Related Correlations Analysis

	ZVSA	PALI	UNCY	APGN	IMMX	REVB	ZURA	PHIO	RNAZ	ICU
ZVSA		0.87	-0.81	0.13	0.12	0.44	0.38	0.44	0.09	0.91	ZVSA
PALI	0.87		-0.75	0.15	0.06	0.3	0.39	0.52	0.13	0.9	PALI
UNCY	-0.81	-0.75		-0.3	0.02	-0.42	-0.22	-0.16	-0.03	-0.78	UNCY
APGN	0.13	0.15	-0.3		-0.18	0.05	0.08	-0.43	0.33	0.02	APGN
IMMX	0.12	0.06	0.02	-0.18		0.52	-0.24	-0.19	-0.75	0.26	IMMX
REVB	0.44	0.3	-0.42	0.05	0.52		0.36	-0.01	-0.32	0.41	REVB
ZURA	0.38	0.39	-0.22	0.08	-0.24	0.36		0.42	0.51	0.24	ZURA
PHIO	0.44	0.52	-0.16	-0.43	-0.19	-0.01	0.42		0.24	0.44	PHIO
RNAZ	0.09	0.13	-0.03	0.33	-0.75	-0.32	0.51	0.24		-0.11	RNAZ
ICU	0.91	0.9	-0.78	0.02	0.26	0.41	0.24	0.44	-0.11		ICU
	ZVSA	PALI	UNCY	APGN	IMMX	REVB	ZURA	PHIO	RNAZ	ICU

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ICU	+ 0.91	ZVSA
ICU	+ 0.9	PALI
PALI	+ 0.87	ZVSA
PHIO	+ 0.52	PALI
REVB	+ 0.52	IMMX
RNAZ	+ 0.51	ZURA

High negative correlations

UNCY	- 0.81	ZVSA
ICU	- 0.78	UNCY
RNAZ	- 0.75	IMMX
UNCY	- 0.75	PALI
PHIO	- 0.43	APGN
REVB	- 0.42	UNCY

Risk-Adjusted Indicators

There is a big difference between TCBP Stock performing well and TC BioPharm Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze TC BioPharm's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ZVSA	3.98	(0.81)	0.00	0.50	0.00	0.00	7.57	(9.60)	78.93
PALI	3.46	(0.36)	0.00	0.61	0.00	0.00	5.97	(8.55)	24.25
UNCY	4.14	1.07	0.19	0.84	4.13	(5.41)	10.26	(7.32)	29.22
APGN	5.12	0.24	(0.01)	(0.08)	5.50	(7.45)	7.89	(11.11)	58.79
IMMX	4.34	(0.06)	(0.01)	0.08	4.54	(5.61)	9.38	(8.22)	32.68
REVB	3.64	(0.67)	0.00	(0.22)	0.00	0.00	8.97	(7.83)	34.52
ZURA	3.81	(0.65)	0.00	(0.17)	0.00	0.00	7.95	(7.94)	26.70
PHIO	4.59	0.00	0.00	0.13	5.56	(5.53)	11.78	(9.23)	36.22
RNAZ	8.17	1.11	0.10	(0.56)	6.97	(12.15)	22.00	(11.43)	68.80
ICU	4.03	(1.09)	0.00	(0.90)	0.00	0.00	7.98	(6.93)	31.31

TC BioPharm Corporate Management

Michael MBA	CoFounder Chairman	Profile
Lauren Bor	Head Division	Profile
Martin Thorp	CFO Director	Profile
Christopher Camarra	Executive Communications	Profile
Bryan Kobel	CEO Director	Profile
Angela Scott	CoFounder COO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC